Ordenar

Buscar

01/02/2026 Lessons from the Colombian kindred: rethinking Alzheimer's prevention
Fortea, J, Llibre-Guerra, J, O'Connor, A, Levin, J. Lessons from the Colombian kindred: rethinking Alzheimer's prevention. LANCET NEUROLOGY. 2026; 25(2)DOI:10.1016/S1474-4422(25)00481-8. PMID:41579884. IF:45.500(Q1/1D).
01/02/2026 Perioperative care in primary retroperitoneal sarcoma surgery: A hispano-luso survey on current practices
Lominchar, PL, Muñoz, P, Ballester, C, Casares, CM, Diaz, D, Olivares-Ripoll, V, Marrero, P, Cambeiro, L, Lopez, I, Vasques, H, Asencio, JM. Perioperative care in primary retroperitoneal sarcoma surgery: A hispano-luso survey on current practices. CIRUGIA ESPANOLA. 2026; 104(2)DOI:10.1016/j.ciresp.2025.800283. PMID:. IF:1.300(Q3/7D).
01/02/2026 Grading of Recommendations, Assessment, Development, and Evaluation guidance 44: strategies to enhance the utilization of randomized and nonrandomized studies in evidence syntheses of healthinterventions
Cuello-Garcia, CA, Morgan, RL, Santesso, N, Alonso-Coello, P, Brignardello-Petersen, R, Schwingshackl, L, Brozek, JL, Katikireddi, SV, Munn, Z, Waddington, HS, Wilson, KC, Meerpohl, J, Morales, D, Neumann, I, Tugwell, P, Guyatt, G, Schünemann, HJ. Grading of Recommendations, Assessment, Development, and Evaluation guidance 44: strategies to enhance the utilization of randomized and nonrandomized studies in evidence syntheses of healthinterventions. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 190DOI:10.1016/j.jclinepi.2025.112086. PMID:41285282. IF:5.200(Q1/1D).
01/02/2026 The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness research
Laurie, C, Coello, PA, Florez, ID, Le, M, Moher, D, Sadarangani, M, Sundaram, ME, Wells, G, Wilkinson, K, Dwan, K, Halperin, SA, Nicholls, SG, Reeves, BC, Waddington, HS, Shea, B, Brouwers, M, Sulis, G. The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness research. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 190DOI:10.1016/j.jclinepi.2025.112088. PMID:41297718. IF:5.200(Q1/1D).
01/02/2026 Appropriateness criteria in the request for carotid ultrasonography. A multicentre study
Armario, P, Bellmunt, S, Rodriguez, JLD, Zapater, CJ, Gich, IJ, Roure, P, Canabal, EF, Requeijo, C. Appropriateness criteria in the request for carotid ultrasonography. A multicentre study. MEDICINA CLINICA. 2026; 166(2)DOI:10.1016/j.medcli.2025.107346. PMID:41548329. IF:2.100(Q2/3D).
01/02/2026 Sex differences in HIV testing in Catalan emergency departments
Robert, N, Miro, E, Llaneras, J, Guardiola, JM, Smithson, A, Leey, C, Bustamante, MA, Ferro, JI, Michelini, M, Martínez, A, Saura, M, Viñas, J, del Castillo, JG, Gené, E, Miro, O. Sex differences in HIV testing in Catalan emergency departments. European Journal of Emergency Medicine. 2026; 33(1)DOI:10.1097/MEJ.0000000000001291. PMID:41258674. IF:4.200(Q1/1D).
01/02/2026 Analysis on workforce availability, education and training needs for medical physics experts to ensure quality and safety of medical applications involving ionising radiation in the EU - Status and recommendations from the EU-REST project
Garibaldi, C, Sánchez, RM, Visvikis, D, Pesznyak, C, Polycarpou, I, Koutsouveli, E, Jornet, N. Analysis on workforce availability, education and training needs for medical physics experts to ensure quality and safety of medical applications involving ionising radiation in the EU - Status and recommendations from the EU-REST project. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2026; 142DOI:10.1016/j.ejmp.2026.105724. PMID:41544482. IF:2.700(Q2/4D).
01/02/2026 Neurodegeneration in Langerhans cell histiocytosis: Beyond a sequela
López, VS, Gutiérrez-Carrasco, I, Pérez-Martinez, A, Iturrate, CRV, Garcia-Obregón, S, Reggiori, ML, Carrillo, TM, Valero-Arrese, L, Torrent, M, Astigarraga, I. Neurodegeneration in Langerhans cell histiocytosis: Beyond a sequela. ANALES DE PEDIATRIA. 2026; 104(2)DOI:10.1016/j.anpedi.2025.504058. PMID:. IF:2.100(Q2/4D).
01/02/2026 Corticosteroid-responsive optic neuritis associated with acute retinal necrosis due to Herpes simplex virus type 2 in a pediatric patient
Montero-Garcia, A, Pérez-Garcia, G, Cobo-De-Nadal, M, Verdú-Reyes, A, Díaz-Cascajosa, J. Corticosteroid-responsive optic neuritis associated with acute retinal necrosis due to Herpes simplex virus type 2 in a pediatric patient. JOURNAL FRANCAIS D OPHTALMOLOGIE. 2026; 49(2)DOI:10.1016/j.jfo.2025.104760. PMID:41512673. IF:1.100(Q3/8D).
01/02/2026 Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort
Ardébol, SB, Pérez-Pastor, GM, Fernández-de-Misa, R, Botella-Estrada, R, Ruiz-Salas, V, Flórez, A, Arenal, MM, González, MJF, Bassas-Freixas, P, Toll, A, Almazán, PV, Arntz, R, Malvehy, J. Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort. Actas Dermo-Sifiliograficas. 2026; 117(2)DOI:10.1016/j.ad.2025.104524. PMID:41352588. IF:(Q/D).
01/02/2026 Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review
Baniandres, O, Franch, IB, Rull, EV, Moya, AI, Pacheco, MLA, Puchades, AM, Sánchez, JPH, Diaz, FJM, Ruiz, AB, Cantero, AG, Lorenzo, EM, Gutierrez, MG, Fernández-Freire, LR, Payeras, AV, Santos, CM, Bel, PH, Ostiz, SH, Montcusi, JP, Salafranca, MA, Segura, PC, Pallas, IM, Masoliver, AA, Manchón, TM, Mucientes, CD, Apetrei, CLS, Martinez, AB, Serrano, JM, Ortega, CP, del Cura, LR, Barragán, IL, Mur, EC, Olivares, MG, Dobao, PD. Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70053. PMID:40931458. IF:3.200(Q1/3D).
01/02/2026 Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors
Ara-Martín, M, Moreno, C, Ruiz-Villaverde, R, Serra-Baldrich, E, Hernández-Martín, I, Fortes, MD. Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70033. PMID:40928003. IF:3.200(Q1/3D).
01/02/2026 Ex-vivo digital pathological imaging with the Vivascope confocal microscopy for intraoperative diagnostics during ureterorenoscopy for upper tract urothelial cancer
Afferi, L, Territo, A, Gallioli, A, Verri, P, Basile, G, Uleri, A, Cannoletta, D, Casadevall, M, Diana, P, Gavrilov, P, Arce, Y, Gaya, JM, Palou, J, Arrea, FA, Breda, A. Ex-vivo digital pathological imaging with the Vivascope confocal microscopy for intraoperative diagnostics during ureterorenoscopy for upper tract urothelial cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(2)DOI:10.1016/j.urolonc.2025.11.009. PMID:41372082. IF:2.300(Q2/5D).
01/02/2026 The impact of large-scale release of Wolbachia mosquitoes on dengue incidence in Campo Grande, Brazil: an ecological study
Batista, FD, Carcamo, PM, Nelson, E, Neto, ABD, Tsuha, DH, Lahdo, V, dos Santos, VR, Ribeiro, GS, Lopes, RD, Amadeu, P, Blanco, MVFM, da Costa, TR, Chalegre, KDD, Riback, TIS, da Silva, CC, Ranzani, OT, Cummings, DAT, Andrews, JR, Ko, AI, Hitchings, MDT, Anders, KL, Moreira, LA, Gonçalves, CCM, Croda, J. The impact of large-scale release of Wolbachia mosquitoes on dengue incidence in Campo Grande, Brazil: an ecological study. Lancet Regional Health-Americas. 2026; 54DOI:10.1016/j.lana.2025.101327. PMID:41438239. IF:(Q/D).
01/02/2026 Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study
Buchmeier, EL, Reck, M, Girard, N, Nadal, E, Gay, CM, Filippi, AR, Martin, LW, Petersen, C, Cairns, DA, Roch, B, Attili, I, Alvarez, RA, Boyer, A, Tarruella, MM, Robinson, A, Levra, MG, Li, L, Perez, ID, Georgoulia, N, Spicer, J. Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).
01/02/2026 International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
Giani, C, Baldi, GG, Ljevar, S, Denu, RA, Andelkovic, V, Han, I, Brunello, A, Napolitano, A, Bhadri, VA, Scanferla, R, Garcia, AS, Abreu, MH, Campos, F, Ogura, K, Wong, DD, Bae, S, Marquina, G, Mazzocca, A, Yang, V, Nakazawa, MS, Kim, HS, Chiusole, B, Thway, K, Antonescu, C, Bellan, E, Bovée, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Chen, TWW, Miceli, R, Gronchi, A, Stacchiotti, S. International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease. ESMO Open. 2026; 11(2)DOI:10.1016/j.esmoop.2025.106044. PMID:41564817. IF:8.300(Q1/2D).
01/02/2026 IMforte: Results from a Phase 3 study of first-line (1L) maintenance treatment (tx) with lurbinectedin (lurbi) plus atezolizumab (atezo) vs atezo in patients (pts) with ES-SCLC
Christoph, D, Paz-Ares, L, Borghaei, H, Liu, S, Peters, S, Herbst, R, Stencel, K, Tarruella, MM, Czyzewicz, G, Caro, RB, Lee, KH, Johnson, ML, Karadurmus, N, Grohé, C, Cuchelkar, V, Graupner, V, Kaul, M, Lin, YC, Chakrabarti, D, Bhatt, K, Reck, M. IMforte: Results from a Phase 3 study of first-line (1L) maintenance treatment (tx) with lurbinectedin (lurbi) plus atezolizumab (atezo) vs atezo in patients (pts) with ES-SCLC. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).
01/02/2026 Socioeconomic Deprivation in Ischemic Stroke Treated With Endovascular Thrombectomy: Not All Recoveries Are Equal
Montalvo, C, Garcia-Tornel, A, Olive-Gadea, M, Rodrigo-Gisbert, M, Requena, M, Rizzo, F, Rodriguez-Luna, D, Rodriguez-Villatoro, N, Pagola, J, Simonetti, R, de la Ossa, NP, Camps-Renom, P, Canovas, D, Flores, A, Rodriguez-Campello, A, Silva, Y, Urra, X, Purroy, F, Bustamante, A, Salvat-Plana, M, Cardona, P, Molina, C, Rubiera, M, Ribo, M. Socioeconomic Deprivation in Ischemic Stroke Treated With Endovascular Thrombectomy: Not All Recoveries Are Equal. STROKE. 2026; 57(2)DOI:10.1161/STROKEAHA.125.052865. PMID:41208686. IF:8.900(Q1/1D).
01/02/2026 White Matter Hyperintensities Are Associated with Worse Outcomes but Not Greater Cerebral Edema or Hemorrhagic Transformation After Large Vessel Occlusion Stroke
Dietz, S, Avula, A, Kumar, A, Petersen, N, Guasch-Jimenez, M, Slowik, A, Wrona, P, Dhar, R. White Matter Hyperintensities Are Associated with Worse Outcomes but Not Greater Cerebral Edema or Hemorrhagic Transformation After Large Vessel Occlusion Stroke. STROKE. 2026; 57(SUPPL_1)DOI:10.1161/str.57.suppl_1.DP035. PMID:. IF:8.900(Q1/1D).
01/02/2026 Cardiac plasmacytoma with extensive infiltration: multimodal diagnosis and therapeutic challenges: a case report
Rodríguez-Fraga, P, Cascos, E, Cuartas, A, Espadaler, I. Cardiac plasmacytoma with extensive infiltration: multimodal diagnosis and therapeutic challenges: a case report. European Heart Journal-Case Reports. 2026; 10(2)DOI:10.1093/ehjcr/ytag102. PMID:41728229. IF:(Q/D).
01/02/2026 Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations
Döhner, H, Schuh, AC, Recher, C, O'Nions, J, Aldoss, I, Piérola, AA, Allred, AJ, Alonso-Dominguez, JM, Barreyro, L, Bories, P, Daskalakis, N, Della Porta, MG, D'Souza, A, Dugan, J, Esteve, J, Fathi, AT, Ferrante, L, Gaj, S, Garciaz, S, Diaz, AG, Salamero, O, Guttke, C, Gyan, E, Hiebert, B, Jabbour, E, Jentzsch, M, Kantarjian, HM, Konopleva, M, Krönke, J, Hütter-Krönke, ML, Loefgren, C, Lomas, O, Mancini, V, Mantzaris, I, Morillo, D, Packman, K, Papayannidis, C, Philippar, U, Platzbecker, U, Paniagua, SG, Sackey, N, Sauer, T, Shastri, PN, Searle, E, Tovar, N, Trancucci, D, Vallet, N, Vaughan, L, Vyas, P, Wei, AH, Rölling, C. Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations. Transplantation And Cellular Therapy. 2026; 32(2)DOI:. PMID:. IF:4.400(Q1/1D).
01/02/2026 Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis
Lopez-Pereira, P, Domínguez, SR, Martin-Moro, F, Caballero, AC, García, AL, Benito, BD, Sarto, MF, Vicente, FD, Marín, JL, Marino, SP, Jiménez-Ubieto, A, Cabirta, A, Gutiérrez, NC, Chulvi, MJL, Puyuelo, A, Prat, AM, Coello, AP, García-Lerma, E, Vilchez, SM. Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis. BONE MARROW TRANSPLANTATION. 2026; 61(2)DOI:10.1038/s41409-025-02772-2. PMID:41310181. IF:5.200(Q1/1D).
01/02/2026 Phase II Interim Results for Rapcabtagene Autoleucel (YTB323) in Patients with First-Line, High-Risk Large B-cell Lymphoma
Westin, J, Chavez, JC, Schuster, SJ, Vucinic, V, Young, PA, Johnson, PC, Bramanti, S, Rambaldi, A, Meijide, JB, Kato, K, Sancho, JM, Kwon, M, Solano, C, Fleming, S, Dahiya, S, García-Sancho, AM, Ramos, PM, Pearson, D, Diallo, S, Zia, A, Segura, E, Masood, A, Barba, P. Phase II Interim Results for Rapcabtagene Autoleucel (YTB323) in Patients with First-Line, High-Risk Large B-cell Lymphoma. Transplantation And Cellular Therapy. 2026; 32(2)DOI:. PMID:. IF:4.400(Q1/1D).
01/02/2026 The role of artificial intelligence in predicting graft survival in kidney transplantation: a systematic review
Di Bello, F, Gallioli, A, Pecoraro, A, Prudhomme, T, Piana, A, Marco, BB, Haberal, HB, Dönmez, MI, Lopez-Abad, A, Cannoletta, D, Mancon, S, Guirado, L, Facundo, C, Kanashiro, AK, Gavrilov, P, Rodriguez-Faba, O, Gaya, JM, Breda, A, Territo, A. The role of artificial intelligence in predicting graft survival in kidney transplantation: a systematic review. Minerva Urology And Nephrology. 2026; 78(1)DOI:10.23736/S2724-6051.25.06559-0. PMID:41697205. IF:4.200(Q1/2D).
01/02/2026 Risk factors associated with inadequacy of empirical treatment in patients with sepsis and bacteremia attended in an emergency department
Motos-Bescós, M, Ruiz-Ramos, J, Agra-Montava, I, Moliné-Pareja, A, Palacio-Alvarez, P, Villarejo-Jiménez, A, Pomar-Solchaga, V. Risk factors associated with inadequacy of empirical treatment in patients with sepsis and bacteremia attended in an emergency department. Revista Espanola de Quimioterapia. 2026; 39(1)DOI:10.37201/req/101.2025. PMID:41521957. IF:2.200(Q3/6D).
01/02/2026 LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY
Lázaro, AR, Mediano, O, Cano, I, Egea, C, Monasterio, M, Muñoz, C, Podzamczer, I, Gonzalez, M, Grau, N, Cabriada, V, Cano, MDP, Dalmases, M, Salord, N, Castelló, C, Ramos, A, Lores, V, Arias, B, Jara, B, Ruiz, C, Horrillo, A, Romero, S, Pozuelo, L, Martinez, D, Boukichou, N, Barbé, F, de la Torre, MS. LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).
01/02/2026 A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology
Huber, H, Montoliu-Gaya, L, Brum, WS, Vávra, J, Yakoub, Y, Weninger, H, Braun-Wohlfahrt, LS, Simrén, J, Boada, M, Ruiz, A, Cano, A, Orellana, A, Valero, S, Cañada, L, Tantinya, N, Nogales, AB, Sanz-Cartagena, P, Dittrich, A, Skoog, I, Sander-Long, M, Ballard, C, Richards, M, O'Leary, M, Clemmensen, FK, Wandall, HHD, Altomare, D, Cantoni, V, Stomrud, E, Palmqvist, S, Lleo, A, Alcolea, D, Iragui, MC, Hernandez, AS, Benejam, B, Toro, LV, Singh, A, Denkinger, MN, Simonsen, AH, Kern, S, Corbett, A, Fortea, J, Honigberg, L, Borroni, B, Hansson, O, Morató, X, Blennow, K, Zetterberg, H, Ashton, NJ. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology. NATURE MEDICINE. 2026; 32(2)DOI:10.1038/s41591-025-04080-0. PMID:41491101. IF:50.000(Q1/1D).
01/02/2026 INTERNATIONAL RECOMMENDATIONS FOR SLEEP AND CIRCADIAN RESEARCH IN AGING AND ALZHEIMER'S DISEASE: A DELPHI CONSENSUS STUDY
André, C, Stankeviciute, L, Michaelian, JC, Antonsdottir, IM, Benca, RM, Coulthard, EJ, D'Rozario, AL, Dijk, DJ, Gimenez, S, Gorgoni, M, Leng, Y, Lucey, BP, Pase, MP, Rainey-Smith, SR, Rosenzweig, I, Spira, AP, Winer, JR, Rauchs, G, Naismith, SL. INTERNATIONAL RECOMMENDATIONS FOR SLEEP AND CIRCADIAN RESEARCH IN AGING AND ALZHEIMER'S DISEASE: A DELPHI CONSENSUS STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).
01/02/2026 followME Fabry Pathfinders real-world registry in Spain and Portugal: Cardiac and renal outcomes with migalastat in patients with Fabry disease
Azevedo, O, Ripoll-Vera, T, Aguiar, P, Torra, R, Climent-Payá, V, Camprodon-Gomez, M, de Juan-Ribera, J, Mendoza, ML, Espinosa, M, Martin, JJF, Oliveira, JP, Fortuny, E, Garcia-Pinilla, JM, Gimeno, JR, Martin, FJM, Aguinaga, A, Vaz, AL, Hiros, J, Jain, V, Rotse, BOV, Torregrosa, V. followME Fabry Pathfinders real-world registry in Spain and Portugal: Cardiac and renal outcomes with migalastat in patients with Fabry disease. MOLECULAR GENETICS AND METABOLISM. 2026; 147(2)DOI:10.1016/j.ymgme.2025.109320. PMID:. IF:3.500(Q2/4D).
01/02/2026 Analysis of trace elements and detection of microorganisms in plant-based meat alternatives: health risk assessment
González, N, Domingo, JL, Soler, S, Alvarez, M, Pavón, V, Samblas, D, Abuín, S, Calderón, J, Ramírez, B, Morral-Puigmal, C, Planell, R, Sabaté, S, Castell, V, Alcalde-Sanz, L, Nadal, M. Analysis of trace elements and detection of microorganisms in plant-based meat alternatives: health risk assessment. Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment. 2026; 43(2)DOI:10.1080/19440049.2025.2602187. PMID:41542880. IF:2.200(Q3/6D).
01/02/2026 Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study
Krüger-Szabo, A, Ameen, A, Serra-Baldrich, E, Armstrong, AW, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2026; 24DOI:. PMID:. IF:3.800(Q1/2D).
01/02/2026 The housing rights crisis and its impact on health
Borrell, C, Carrere, J, Pérez, K. The housing rights crisis and its impact on health. Gaceta Sanitaria. 2026; 40DOI:10.1016/j.gaceta.2026.102567. PMID:41702336. IF:1.500(Q3/7D).
01/02/2026 Patients' Needs and Expectations for the Application of Prevention of Drug-related Problems Prevention Programs
Llopis, AV, Ruiz-Ramos, J, Díaz, AP, Campmany, MP, Alvarez, AB, Sampol-Mayol, C, Juanes-Borrego, A. Patients' Needs and Expectations for the Application of Prevention of Drug-related Problems Prevention Programs. Journal Of Research In Pharmacy Practice. 2026; 15(1)DOI:10.4103/jrpp.jrpp_32_25. PMID:41969590. IF:(Q/D).
01/02/2026 Low-severity emergencies in older patients: clarifications to improve validity and applicability
Montava, IA, Ontiveros, HH, Rizzi, M. Low-severity emergencies in older patients: clarifications to improve validity and applicability. EMERGENCIAS. 2026; 38(1)DOI:10.55633/s3me/087.2025. PMID:41575431. IF:6.300(Q1/1D).
01/02/2026 Careful ventilation in acute respiratory distress syndrome: the protocol of the CAVIARDS international multicentre randomised basket trial
Coudroy, R, Telias, I, Jonkman, A, Thille, AW, Diehl, J, Péron, N, Ko, MT, Bourion, AA, Tiribelli, N, Fredes, S, Gutiérrez, M, Bruno, AM, Vasquez, DN, Pratto, RA, Plotnikow, GA, Bianchini, F, Accoce, M, Dorado, J, Spadaro, S, La Rosa, R, Prat, G, Bailly, P, Delbove, A, Pacheco-Reyes, A, Roca, O, Kuteifan, K, Rouzé, A, Grieco, DL, Izura-Gómez, M, Mancebo, J, Sigaud, F, Terzi, N, Saccheri, C, Dellamonica, J, Richecoeur, J, Setten, M, Rauseo, M, Beloncle, F, Repusseau, B, Rozé, H, Tran-Van, D, Damiani, F, Slama, M, Kaufman, DA, Maraffi, T, Goligher, EC, Plantefève, G, Determann, R, Giamou, M, Pham, T, Del Sorbo, L, Keown-Stoneman, CDG, Nisenbaum, R, Thorpe, K, Piraino, T, Chen, L, Jüni, P, Ferguson, ND, Slutsky, AS, Brochard, L. Careful ventilation in acute respiratory distress syndrome: the protocol of the CAVIARDS international multicentre randomised basket trial. BMJ Open. 2026; 16(2)DOI:10.1136/bmjopen-2025-115775. PMID:41730551. IF:2.300(Q2/3D).
01/02/2026 Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison
Chovatiya, R, Armstrong, A, Kircik, L, Puig, L, Kirchhof, MG, Torres, T, Binamer, Y, Duarte, G, Akmaz, B, Dossenbach, M, Gallo, G, Yang, C, Seminario-Vidal, L, Ding, YX, Silverberg, JI. Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-025-01620-x. PMID:41420795. IF:4.200(Q1/1D).
01/02/2026 Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study
Torres, T, Sood, S, Yilmaz, O, Vender, RB, Prajapati, VH, Puig, L, Megna, M, Marzano, AV, Gisondi, P, Carrascosa, JM, Dauden, E, Llamas-Velasco, M, Balato, A, Leal, BG, Prignano, F, Bellinato, F, Silvi, G, Di Brizzi, EV, Potestio, L, Carrera, CG, López-Ferrer, A, Del-Alcazar, E, Mufti, A, Maul, LV, Piaserico, S, Maul, JT, Yeung, JS. Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-026-01653-w. PMID:41575604. IF:4.200(Q1/1D).
01/02/2026 Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study
Díaz, JM, Alarcon, SS, Romero, IB, Apetrei, LS, Fernández, LG, Ramos, FJM, Alberola, FT, Martínez, MAB, Ruiz, AB, Rodríguez, OB, Ruiz-Villaverde, R, González, MC, Farrés, MF, Puchades, AM, Tapial, JM, Rull, EV, Montalvo, SM. Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2026; 67(1)DOI:10.1111/ajd.70012. PMID:41347368. IF:1.800(Q3/6D).
01/02/2026 Management of Obesity in Psoriasis Consultations
Nicolau, J, López-Ferrer, A, de la Cueva, P. Management of Obesity in Psoriasis Consultations. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-026-01664-7. PMID:41627722. IF:4.200(Q1/1D).
01/02/2026 Intrahepatic Versus Extrahepatic Biliary Tree Cysts: Outcomes after Surgical Resection in a Multicentric Study
Ferrari, C, D'Ambrosio, GM, Martin, B, Romera, AG, Molina, V, Griseri, G, Moral, A, Sánchez-Cabús, S. Intrahepatic Versus Extrahepatic Biliary Tree Cysts: Outcomes after Surgical Resection in a Multicentric Study. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2026; 36(2)DOI:10.1177/10926429251408365. PMID:41467982. IF:1.100(Q3/7D).